Hemodynamic and metabolic alterations in response to graded exercise in a patient susceptible to malignant hyperthermia

Anesthesiology

Volumn 92, Issue 1, 2000, Pages 268-272

  Wappler, Frank ^a   Fiege, Marko ^a   Antz, Matthias ^a   Schulte Am Esch, Jochen ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Caffeine; Halothane; Stress

Indexed keywords

ANESTHETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; DANTROLENE; HALOTHANE;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CASE REPORT; EXERCISE TEST; HEMODYNAMIC PARAMETERS; HUMAN; HUMAN TISSUE; MALE; MALIGNANT HYPERTHERMIA; METABOLIC PARAMETERS; MUSCLE BIOPSY; MUSCLE WEAKNESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

EID: 0033961246     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200001000-00042     Document Type: Article

References (23)

1. Gronert GA, Antognini JF, Pessah IN: Malignant hyperthermia, Anesthesia, 5th Edition. Edited by Miller RD. New York, Churchill Livingstone, 2000, pp 1033-52
2. Ellis FR, Campbell IT: Fatal heat stroke in a long distance runner (letter). BMJ 1983; 287:1548-9
3. Gronert GA, Thompson RL, Onofrio BM: Human malignant hyperthermia: Awake episodes and correction by dantrolene. Anesth Analg 1980; 59:377-8
4. Hackl W, Winkler M, Mauritz W, Sporn P, Steinbereithner K: Muscle biopsy for diagnosis of malignant hyperthermia susceptibility in two patients with severe exercise-induced myolysis. Br J Anaesth 1991; 66:138-40
5. Hopkins PM, Ellis FR, Halsall PJ: Evidence for related myopathies in exertional heat stroke and malignant hyperthermia. Lancet 1991; 338:1491-2
6. Jardon OM: Physiologic stress, heat stroke, malignant hyperthermia: A perspective. Military Med 1982; 147:8-14
7. Köchling A, Wappler F, Winkler G, Schulte am Esch J: Rhabdomyolysis following severe physical exercise in a patient with predisposition to malignant hyperthermia. Anaesth Intensive Care 1998; 26:315-8
8. Roewer N, Dziadzka A, Greim CA, Kraas E, Schulte am Esch J: Cardiovascular and metabolic responses to anesthetic-induced malignant hyperthermia in swine. ANESTHESIOLOGY 1995; 83:141-59
9. 2 receptors induces malignant hyperthermia. Naunyn-Schmiedeberg's Arch Pharmacol 1990; 341:483-93
10. Wappler F, Roewer N, Köchling A, Scholz J, Löscher W. Steinfath M, Schulte am Esch J: Effects of the serotonin, receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia susceptible patients. ANESTHESIOLOGY 1996; 84:1280-7
11. 2+ release channels. Am J Med 1998; 104:470-86
12. Ørding H, Brancadoro V, Cozzolino S, Ellis FR, Glauber V, Gonano EF, Halsall PJ, Hartung E, Heffron JJA, Heytens L, Kozak-Ribbens G, Kress H, Krivosic-Horber R, Lehmann-Horn F, Mortier W, Nivoche Y, Ranklev-Twetman E, Sigurdson S, Snoeck M, Stieglitz P, Tegazzin V, Urwyler A, Wappler F: In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and un-related low-risk subjects. Acta Anaesthesiol Scand 1997; 41:955-66
13. Wappler F, Roewer N, Köchling A, Scholz J, Steinfath M, Schulte am Esch J: In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles. Anesth Analg 1996; 82:1230-6
14. 2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermia. Hum Mol Genet 1994; 3:2181-6
15. Ogletree JW, Antognini JF, Gronert GA: Postexercise muscle cramping associated with positive malignant hyperthermia contracture testing. Am J Sports Med 1996; 24:49-51
16. Haverkort-Poels PJ, Joosten EM, Ruitenbeek W: Prevention of recurrent exertional rhabdomyolysis by dantrolene sodium. Muscle Nerve 1987; 10:45-6
17. Campbell IT, Ellis FR, Evans RT: Metabolic rate and blood hormone and metabolite levels of individuals susceptible to malignant hyperpyrexia at rest and in response to food and mild exercise. ANESTHESIOLOGY 1981; 55:46-52
18. Campbell IT, Ellis FR, Evans RT, Mortimer MG: Studies of body temperature, blood lactate, cortisol and free fatty acid levels during exercise in human subjects susceptible to malignant hyperthermia. Acta Anaesthesiol Scand 1983; 27:349-55
19. Green JH, Ellis FR, Halsall PJ, Campbell IT, Currie S, Caddy J: Thermoregulation, plasma catecholamine and metabolite levels during submaximal work in individuals susceptible to malignant hyperpyrexia. Acta Anaesthesiol Scand 1987; 31:122-6
20. Rutberg H, Hakanson E, Hall GM, Jorfeldt L: Effects of graded exercise on leg exchange of energy substrates in malignant hyperthermia susceptible subjects. ANESTHESIOLOGY 1987; 67:308-13
21. Gronert GA, Milde JH, Theye RA: Role of sympathetic activity in porcine malignant hyperthermia. ANESTHESIOLOGY 1977; 47:411-5
22. Urwyler A, Censier K, Seeberger MD, Rothenbühler JM, Kaufmann MA, Drewe J: In vitro effect of ephedrine, adrenaline, noradrenaline and isoprenaline on halothane-indnced contractures in skeletal muscle from patients potentially susceptible to malignant hyperthermia. Br J Anaesth 1993; 70:76-9
23. Gerdes C, Richter A, Annies R. Löscher W: Increase of serotonin in plasma during onset of halothane-induced malignant hyperthermia in pigs. Eur J Pharmacol 1992; 220:91-4